$ALRM Cashflow Statement | Understand Stock

$ALRM

$64.59 +$0.45 (0.7%) Close

$ALRM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash flows from operating activities:
Provision for credit losses on accounts receivable
Reserve for product returns
Provision for credit losses on notes receivable
Inventory write-down
Amortization on patents and tooling
Amortization and depreciation
Amortization of debt issuance costs
Amortization of operating leases
Deferred income taxes
Change in fair value of contingent liability
Stock-based compensation
Gain on notes receivable
Acquired in-process research and development
Gain on sale of investment
(Gain on) / impairment of investment or intangible assets
Distributions on investments in unconsolidated entities
Gain on from investments in unconsolidated entities
Loss on early extinguishment of debt
Other adjustments
Changes in operating assets and liabilities (net of business acquisitions):
Accounts receivable
Inventory
Other current and non-current assets
Accounts payable and other current liabilities
Deferred revenue
Operating lease liabilities
Other liabilities

Cash flows from operating activities
Cash flows used in investing activities:
Business acquisitions, net of cash acquired
Additions to property and equipment
Purchases of in-process research and development
Issuances of notes receivable
Capitalized software development costs
Receipt of payments on notes receivable
Proceeds from sale of investment
Proceeds from sale of investments in unconsolidated entities
Purchase of investments in unconsolidated entities
Purchases of other intangible assets
Cash flows used in investing activities

Cash flows (used in) / from financing activities:
Proceeds from credit facility
Repayments of credit facility
Proceeds from issuance of convertible senior notes
Payments of debt issuance costs
Purchases of capped calls related to convertible senior notes
Payments of deferred consideration for acquisitions
Purchases of treasury stock, including transaction costs
Purchases of redeemable noncontrolling interest
Payments of acquired debt
Payments of tax withholdings related to vesting of restricted stock units
Issuances of common stock from equity-based plans
Cash flows (used in) / from financing activities

Effect of exchange rate changes on cash, cash equivalents and restricted cash
Net (decrease) / increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of the period
Cash, cash equivalents and restricted cash at end of the period
Supplemental disclosures:
Cash paid for interest
Cash paid for income taxes, net of refunds
Noncash investing and financing activities:
Cash not yet paid for capital expenditures
Cash not yet paid for business and asset acquisitions and investments - holdback and working capital adjustments
Conversion of notes receivable and other assets to investments in unconsolidated entities
Contingent liability from business acquisition
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Restricted cash included in other current assets and other assets

Comments